Filing Flows

Filing Flows › Companies › Veracyte › Timeline

Veracyte stock timeline

A year of the price with every insider trade, planned sale, earnings report and material 8-K marked

252 sessions−42.1% to $24.16

Veracyte (VCYT) stock fell 42% over the last 252 sessions, to $24.16. On the way it reported 4 quarters, its insiders filed 3 open-market trades and 9 Form 144 notices of planned sales, and the company filed 3 material 8-Ks. Each is marked on the price and listed with what the stock did next.

VCYT: a year of the stock with every disclosure on itVCYT: a year of the stock with every disclosure on it$31.67$42.26$52.84$63.43▼2025-11-07 · Wygant Jonathan sold $234K▼2025-11-10 · Wygant Jonathan sold $216K●2026-02-25 · Earnings: beat the EPS estimate by 29.8%◆2026-03-16 · Directors and officers: departures, appointments, pay●2026-05-05 · Earnings: beat the EPS estimate by 56.0%▼2026-05-22 · Wygant Jonathan sold $1.1M◆2026-06-11 · Directors and officers: departures, appointments, pay●2026-07-30 · Earnings: beat the EPS estimate by 25.1%▽2026-09-01 · Form 144: Muna Bhanji plans to sell $161K▽2026-09-04 · Form 144: Ann McGuire plans to sell $145K▽2026-09-04 · Form 144: Rebecca Chambers plans to sell $163K▽2026-09-04 · Form 144: Phillip Febbo plans to sell $586K▽2026-09-14 · Form 144: Jens Holstein plans to sell $205K◆2026-09-14 · Material definitive agreement▽2026-09-21 · Form 144: John Leite plans to sell $160K▽2026-09-24 · Form 144: Jens Holstein plans to sell $352K▽2026-10-27 · Form 144: Karin Eastham plans to sell $716K▽2026-10-27 · Form 144: Jens Holstein plans to sell $375K●2026-11-04 · Earnings: beat the EPS estimate by 24.5%▼Insider sale●Earnings report◆8-K event▽Planned sale (Form 144)2025-11-062026-11-06
Daily closes, Nov 6, 2025 to Nov 6, 2026; hover a mark for the filing.

Each mark, and what followed

DateKindWhatNext session5 sessions21 sessions
Nov 4, 2026EarningsEarnings: beat the EPS estimate by 24.5%+4.3% (+2.7% vs SPY)——
Oct 27, 2026Form 144Form 144: Jens Holstein plans to sell $375K+4.2% (+3.7% vs SPY)+1.6% (+3.4% vs SPY)—
Oct 27, 2026Form 144Form 144: Karin Eastham plans to sell $716K+4.2% (+3.7% vs SPY)+1.6% (+3.4% vs SPY)—
Sep 24, 2026Form 144Form 144: Jens Holstein plans to sell $352K+10.2% (+10.3% vs SPY)+4.9% (+5.6% vs SPY)+4.9% (+5.5% vs SPY)
Sep 21, 2026Form 144Form 144: John Leite plans to sell $160K+4.2% (+2.7% vs SPY)+13.3% (+12.0% vs SPY)+9.6% (+9.0% vs SPY)
Sep 14, 20268-KMaterial definitive agreement−2.6% (−2.2% vs SPY)+0.7% (−1.2% vs SPY)+4.5% (+2.0% vs SPY)
Sep 14, 2026Form 144Form 144: Jens Holstein plans to sell $205K+0.8% (+1.3% vs SPY)−2.7% (−2.6% vs SPY)+7.4% (+5.4% vs SPY)
Sep 4, 2026Form 144Form 144: Phillip Febbo plans to sell $586K−4.9% (−4.5% vs SPY)−8.9% (−7.7% vs SPY)+6.5% (+6.0% vs SPY)
Sep 4, 2026Form 144Form 144: Rebecca Chambers plans to sell $163K−4.9% (−4.5% vs SPY)−8.9% (−7.7% vs SPY)+6.5% (+6.0% vs SPY)
Sep 4, 2026Form 144Form 144: Ann McGuire plans to sell $145K−4.9% (−4.5% vs SPY)−8.9% (−7.7% vs SPY)+6.5% (+6.0% vs SPY)
Sep 1, 2026Form 144Form 144: Muna Bhanji plans to sell $161K+0.6% (+1.2% vs SPY)−1.7% (−1.6% vs SPY)+6.4% (+6.7% vs SPY)
Jul 30, 2026EarningsEarnings: beat the EPS estimate by 25.1%+7.1% (+5.4% vs SPY)−18.8% (−24.2% vs SPY)−20.8% (−26.4% vs SPY)
Jun 11, 20268-KDirectors and officers: departures, appointments, pay−0.2% (−0.7% vs SPY)+12.3% (+10.8% vs SPY)+17.7% (+15.6% vs SPY)
May 22, 2026Insider saleWygant Jonathan sold $1.1M−0.4% (−0.7% vs SPY)+2.5% (+0.7% vs SPY)+17.4% (+18.4% vs SPY)
May 5, 2026EarningsEarnings: beat the EPS estimate by 56.0%−1.4% (−2.2% vs SPY)+17.1% (+14.2% vs SPY)+37.5% (+32.6% vs SPY)
Mar 16, 20268-KDirectors and officers: departures, appointments, pay+1.7% (+1.4% vs SPY)+1.9% (+3.7% vs SPY)+3.3% (−1.4% vs SPY)
Feb 25, 2026EarningsEarnings: beat the EPS estimate by 29.8%+0.1% (−0.8% vs SPY)−1.7% (−0.7% vs SPY)−8.5% (−4.2% vs SPY)
Nov 10, 2025Insider saleWygant Jonathan sold $216K+1.6% (0.0% vs SPY)−5.8% (−5.9% vs SPY)+5.0% (+3.2% vs SPY)
Nov 7, 2025Insider saleWygant Jonathan sold $234K0.0% (−0.1% vs SPY)−4.5% (−4.7% vs SPY)+6.2% (+4.2% vs SPY)

Insiders’ record here

In the year on the chart, Veracyte's insiders reported 0 open-market buys ($0) and 3 sales ($1.5M). Of the 3 old enough to score, 3 were followed by the stock doing what the trade implied over the next 63 sessions (beating SPY after a buy, lagging it after a sale); the median excess return after a buy was — and after a sale −14.3%.

Across the whole universe (19,782 scored trades), insider buys beat the market 46% of the time and sales were followed by a lagging stock 61% of the time; buys of $1M or more 39%. Every pattern →

What this kind of 8-K usually did

Item8-KsNext session, medianUp next session21 sessions, medianTypical size
5.02 Directors and officers: departures, appointments, pay39,174−0.1%48%+0.7%±1.4%
1.01 Material definitive agreement23,5250.0%51%+1.0%±1.4%
2.01 Completed acquisition or disposition2,671+0.1%52%+1.2%±1.6%

Across every company in the move-odds universe, measured from the close before the filing. Every 8-K item ranked →

Report card: every quarter against the estimate → Veracyte: every quarter → Live insider trades →

Prices are daily closes; filings and trades are as filed with the SEC (Form 4 within two business days of the trade, 8-K within four of the event). Moves after a mark are the stock's close-to-close change and the same for SPY; they describe the record, not what the next one will do. Not investment advice.